Doctor profile · Federal record
Dr. Andres Redondo, MD
Pulmonary Disease Physician (CMS: Pulmonary Disease) · Miami, FL
- NPI 1558369165
- Accepts Medicare
- MIPS 99.2 / 100 · 2023
- 44 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
3181 Sw 22 Street, 2Nd Floor
Miami, FL 331453216
(305) 567-1999
fax (305) 567-9309
Credentials & registration
- NPI registered
- July 2005 — 21 yrs on file
- Profile last updated
- June 17, 2010
- Year of graduation
- 1982 — 44 yrs since
- Specialty taxonomy
- 207RP1001X — NUCC code
- State license (1)
- Florida #ME0045903
- Medicaid
- FL #047898900
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1558369165. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
937
Distinct HCPCS
9
Medicare allowed
$78,220
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 336 | 168 | $138 | |
94664 |
Evaluation of use of breathing device | 118 | 79 | $18 | |
94060 |
Test to measure expiratory airflow and volume changes before and after medication administration | 95 | 87 | $41 | |
94727 |
Test to determine lung volumes using gas dilution or washout | 92 | 86 | $46 | |
94729 |
Test to examine how well the lungs exchange gases | 92 | 86 | $60 | |
71046 |
X-ray of chest, 2 views | 89 | 79 | $36 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 55 | 55 | $181 | |
94618 |
Test for exercise-induced lung stress | 46 | 42 | $36 | |
G0399 |
Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 14 | 14 | $98 |
In context: peer comparison
Among 33 peers in Miami Pulmonary Disease Physician, average services per provider: 130. This provider delivers 7.2× the peer median.Open Payments
Industry payments received
All-time total
$477
Transactions
23
Manufacturers
5
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| GlaxoSmithKline, LLC. | 10 | $204.09 | |
| AstraZeneca Pharmaceuticals Lp | 9 | $189.20 | |
| Regeneron Healthcare Solutions, INC. | 2 | $56.92 | |
| Genzyme Corporation | 1 | $13.58 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 1 | $13.43 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
13,292
Patients
3,350
Total drug cost
$2,660,392
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa (Albuterol Sulfate) | Brand | 3,209 | 771 | $101,632 |
| Fluticasone Propionate | Generic | 1,768 | 473 | $20,418 |
| Montelukast Sodium | Generic | 1,714 | 418 | $12,540 |
| Symbicort (Budesonide/Formoterol Fumarate) | Brand | 1,074 | 251 | $473,579 |
| Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) | Brand | 916 | 179 | $652,263 |
| Spiriva Respimat (Tiotropium Bromide) | Brand | 746 | 172 | $415,220 |
| Fluticasone-Salmeterol (Fluticasone Propion/Salmeterol) | Brand | 731 | 168 | $128,338 |
| Breo Ellipta (Fluticasone/Vilanterol) | Brand | 676 | 147 | $292,741 |
| Atrovent Hfa (Ipratropium Bromide) | Brand | 455 | 119 | $226,806 |
| Wixela Inhub (Fluticasone Propion/Salmeterol) | Brand | 373 | 107 | $71,929 |
Frequently asked questions
What is Dr. Andres Redondo's medical specialty?
Dr. Andres Redondo practices Pulmonary Disease Physician in Miami, FL.
Where does Dr. Andres Redondo practice?
Dr. Andres Redondo practices at 3181 Sw 22 Street, Miami, FL 331453216. Office phone: 3055671999.
What is Dr. Andres Redondo's NPI?
Dr. Andres Redondo's National Provider Identifier (NPI) is 1558369165, issued by NPPES.
Does Dr. Andres Redondo accept Medicare assignment?
Yes. Dr. Andres Redondo accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Andres Redondo commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Evaluation of use of breathing device (HCPCS 94664); Test to measure expiratory airflow and volume changes before and after medication administration (HCPCS 94060). Source: CMS Medicare Physician & Other Practitioners file.